Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

ET Pharma

GSK, Moderna settle patent dispute over Moderna COVID, RSV shots

Nov 7, 2026, 2:05 AM

Read Full Article →

Translate article text

Choose a language and wait for the translated text.

GSK had sued Moderna in 2024 over lipid nanoparticle technology used in the vaccines to transport fragile messenger RNA (mRNA) into the human body

GSK, Moderna settle patent dispute over Moderna COVID, RSV shots | PharmaVoice